• Discovered by Brian Sathianathan
Claim this
Startup
Write to the

About Cambridge Epigenetix

Our starting point is TrueMethylTM oxidative bisulfite sequencing (oxBS-Seq), a novel technology that pioneers quantitative, single-base resolution sequencing of the modified bases hydroxymethyl cytos...

Sample startup success signal Increased Conversion Rate By

50.0%

Verified by Iterate and ASD IT
Posted by Jon Nordmark,
CEO at Iterate.ai,
June, 2016

Cambridge Epigenetix describes itself with 5 words or categories

Health CareClinical TrialsHospitalsBiotechnologyHealth Diagnostics

Solutions offered by Cambridge Epigenetix

Video

Presentation

Case Study

Competitive Landscape

Capitalization

  • #DATA_YEAR# : $
    #NAME#
    from #DATA_FROM#
  • News

    No news added yet.